1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Cell and Developmental Biology
  4. Volume 38, 2022
  5. Article

Annual Review of Cell and Developmental Biology

Volume 38, 2022

Physiological Functions of Intracellular Protein Degradation

Abstract

While cellular proteins were initially thought to be stable, research over the last decades has firmly established that intracellular protein degradation is an active and highly regulated process: Lysosomal, proteasomal, and mitochondrial degradation systems were identified and found to be involved in a staggering number of biological functions. Here, we provide a global overview of the diverse roles of cellular protein degradation using seven categories: homeostasis, regulation, quality control, stoichiometry control, proteome remodeling, immune surveillance, and baseline turnover. Using selected examples, we outline how proteins are degraded and why this is functionally relevant.

Keyword(s): autophagy, protein degradation, protein quality control, ubiquitin proteasome system
Loading

Article metrics loading...

/content/journals/10.1146/annurev-cellbio-120420-091943
2022-10-06
2024-04-29
Loading full text...

Full text loading...

/deliver/fulltext/cellbio/38/1/annurev-cellbio-120420-091943.html?itemId=/content/journals/10.1146/annurev-cellbio-120420-091943&mimeType=html&fmt=ahah

Literature Cited

  1. Aebersold R, Mann M. 2016. Mass-spectrometric exploration of proteome structure and function. Nature 537:7620347–55
     [Google Scholar]
  2. Aebi M, Bernasconi R, Clerc S, Molinari M. 2010. N-glycan structures: recognition and processing in the ER. Trends Biochem. Sci. 35:274–82
     [Google Scholar]
  3. Alberts B, Johnson A, Lewis J, Morgan D, Raff M et al. 2015. Molecular Biology of the Cell New York: Garland Science. , 6th ed..
  4. An H, Harper JW. 2018. Systematic analysis of ribophagy in human cells reveals bystander flux during selective autophagy. Nat. Cell Biol. 20:2135–43
     [Google Scholar]
  5. An H, Ordureau A, Körner M, Paulo JA, Harper JW. 2020. Systematic quantitative analysis of ribosome inventory during nutrient stress. Nature 583:7815303–9
     [Google Scholar]
  6. An X, Schulz VP, Li J, Wu K, Liu J et al. 2014. Global transcriptome analyses of human and murine terminal erythroid differentiation. Blood 123:223466–77
     [Google Scholar]
  7. Antón LC, Yewdell JW. 2014. Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors. J. Leukoc. Biol. 95:4551–62
     [Google Scholar]
  8. Babbitt BP, Allen PM, Matsueda G, Haber E, Unanue ER. 1985. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature 317:6035359–61
     [Google Scholar]
  9. Ballabio A, Bonifacino JS. 2020. Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat. Rev. Mol. Cell Biol. 21:2101–18
     [Google Scholar]
  10. Bard JAM, Goodall EA, Greene ER, Jonsson E, Dong KC, Martin A. 2018. Structure and function of the 26S proteasome. Annu. Rev. Biochem. 87:697–724
     [Google Scholar]
  11. Bassani-Sternberg M, Pletscher-Frankild S, Jensen LJ, Mann M. 2015. Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation. Mol. Cell. Proteom. 14:3658–73
     [Google Scholar]
  12. Battle A, Khan Z, Wang SH, Mitrano A, Ford MJ et al. 2015. Impact of regulatory variation from RNA to protein. Science 347:6222664–67
     [Google Scholar]
  13. Bingol B, Schuman EM. 2006. Activity-dependent dynamics and sequestration of proteasomes in dendritic spines. Nature 441:70971144–48
     [Google Scholar]
  14. Bischoff TLW, Voit C. 1860. Die Gesetze der Ernährung des Fleischfressers durch neue Untersuchungen festgestellt [The laws of the carnivore's diet established by recent investigations]. Leipzig, Ger.: C.F. Winter
     [Google Scholar]
  15. Blikstad I, Nelson WJ, Moon RT, Lazarides E. 1983. Synthesis and assembly of spectrin during avian erythropoiesis: stoichiometric assembly but unequal synthesis of α and β spectrin. Cell 32:41081–91
     [Google Scholar]
  16. Bogenhagen DF, Haley JD. 2020. Pulse-chase SILAC-based analyses reveal selective over-synthesis and rapid turnover of mitochondrial protein components of respiratory complexes. J. Biol. Chem. 295:92544–54
     [Google Scholar]
  17. Bonam SR, Wang F, Muller S. 2019. Lysosomes as a therapeutic target. Nat. Rev. Drug Discov. 18:12923–48
     [Google Scholar]
  18. Bourdetsky D, Schmelzer CEH, Admon A. 2014. The nature and extent of contributions by defective ribosome products to the HLA peptidome. PNAS 111:16E1591–99
     [Google Scholar]
  19. Brennan CM, Vaites LP, Wells JN, Santaguida S, Paulo JA et al. 2019. Protein aggregation mediates stoichiometry of protein complexes in aneuploid cells. Genes Dev 33:1031–47
     [Google Scholar]
  20. Brown MG, Driscoll J, Monaco JJ. 1991. Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes. Nature 353:6342355–57
     [Google Scholar]
  21. Buccitelli C, Selbach M. 2020. mRNAs, proteins and the emerging principles of gene expression control. Nat. Rev. Genet. 21:10630–44
     [Google Scholar]
  22. Buchberger A, Bukau B, Sommer T. 2010. Protein quality control in the cytosol and the endoplasmic reticulum: brothers in arms. Mol. Cell 40:2238–52
     [Google Scholar]
  23. Burslem GM, Crews CM. 2020. Proteolysis-targeting chimeras as therapeutics and tools for biological discovery. Cell 181:1102–14
     [Google Scholar]
  24. Cabrera M, Boronat S, Marte L, Vega M, Pérez P et al. 2020. Chaperone-facilitated aggregation of thermo-sensitive proteins shields them from degradation during heat stress. Cell Rep 30:72430–43.e4
     [Google Scholar]
  25. Cambridge SB, Gnad F, Nguyen C, Bermejo JL, Krüger M, Mann M. 2011. Systems-wide proteomic analysis in mammalian cells reveals conserved, functional protein turnover. J. Proteome Res. 10:125275–84
     [Google Scholar]
  26. Chen G, Kroemer G, Kepp O. 2020. Mitophagy: an emerging role in aging and age-associated diseases. Front. Cell Dev. Biol. 8:200
     [Google Scholar]
  27. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW et al. 1990. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63:4827–34
     [Google Scholar]
  28. Chick JM, Munger SC, Simecek P, Huttlin EL, Choi K et al. 2016. Defining the consequences of genetic variation on a proteome-wide scale. Nature 534:7608500–5
     [Google Scholar]
  29. Dang F, Nie L, Wei W. 2021. Ubiquitin signaling in cell cycle control and tumorigenesis. Cell Death Differ 28:2427–38
     [Google Scholar]
  30. Dephoure N, Hwang S, O'Sullivan C, Dodgson SE, Gygi SP et al. 2014. Quantitative proteomic analysis reveals posttranslational responses to aneuploidy in yeast. eLife 3:e03023
     [Google Scholar]
  31. Desautels M, Goldberg AL. 1982. Liver mitochondria contain an ATP-dependent, vanadate-sensitive pathway for the degradation of proteins. PNAS 79:61869–73
     [Google Scholar]
  32. Deshwal S, Fiedler KU, Langer T. 2020. Mitochondrial proteases: multifaceted regulators of mitochondrial plasticity. Annu. Rev. Biochem. 89:501–28
     [Google Scholar]
  33. Dieterich DC, Link AJ, Graumann J, Tirrell DA, Schuman EM. 2006. Selective identification of newly synthesized proteins in mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT). PNAS 103:259482–87
     [Google Scholar]
  34. Dikic I. 2017. Proteasomal and autophagic degradation systems. Annu. Rev. Biochem. 86:193–224
     [Google Scholar]
  35. Dikic I, Elazar Z. 2018. Mechanism and medical implications of mammalian autophagy. Nat. Rev. Mol. Cell Biol. 19:349–64
     [Google Scholar]
  36. Doherty MK, Hammond DE, Clague MJ, Gaskell SJ, Beynon RJ. 2009. Turnover of the human proteome: determination of protein intracellular stability by dynamic SILAC. J. Proteome Res. 8:1104–12
     [Google Scholar]
  37. Donaldson JG, Williams DB. 2009. Intracellular assembly and trafficking of MHC class I molecules. Traffic 10:121745–52
     [Google Scholar]
  38. Dörrbaum AR, Alvarez-Castelao B, Nassim-Assir B, Langer JD, Schuman EM. 2020. Proteome dynamics during homeostatic scaling in cultured neurons. eLife 9:e52939
     [Google Scholar]
  39. Duttler S, Pechmann S, Frydman J. 2013. Principles of cotranslational ubiquitination and quality control at the ribosome. Mol. Cell 50:3379–93
     [Google Scholar]
  40. Dzierzak E, Philipsen S. 2013. Erythropoiesis: development and differentiation. Cold Spring Harb. Perspect. Med. 3:4a011601
     [Google Scholar]
  41. Eichelbaum K, Krijgsveld J. 2014. Rapid temporal dynamics of transcription, protein synthesis, and secretion during macrophage activation. Mol. Cell. Proteom. 13:3792–810
     [Google Scholar]
  42. Engelhard VH. 2003. Structure of peptides associated with class I and class II MHC molecules. Annu. Rev. Immunol. 12:181–207
     [Google Scholar]
  43. Evans T, Rosenthal ET, Youngblom J, Distel D, Hunt T. 1983. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 33:2389–96
     [Google Scholar]
  44. Fiorese CJ, Schulz AM, Lin Y-F, Rosin N, Pellegrino MW, Haynes CM. 2016. The transcription factor ATF5 mediates a mammalian mitochondrial UPR. Curr. Biol. 26:152037–43
     [Google Scholar]
  45. Fleming JA, Lightcap ES, Sadis S, Thoroddsen V, Bulawa CE, Blackman RK. 2002. Complementary whole-genome technologies reveal the cellular response to proteasome inhibition by PS-341. PNAS 99:31461–66
     [Google Scholar]
  46. Folin OK. 1905. Laws governing the chemical composition of urine: approximately complete analyses of thirty “normal” urines. A theory of protein metabolism. Am. J. Physiol. 13:67–115
     [Google Scholar]
  47. Geiger T, Cox J, Mann M. 2010. Proteomic changes resulting from gene copy number variations in cancer cells. PLOS Genet 6:9e1001090
     [Google Scholar]
  48. Giandomenico SL, Alvarez-Castelao B, Schuman EM. 2022. Proteostatic regulation in neuronal compartments. Trends Neurosci 45:141–52
     [Google Scholar]
  49. Glynne R, Powis SH, Beck S, Kelly A, Kerr LA, Trowsdale J. 1991. A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 353:6342357–60
     [Google Scholar]
  50. Goldberg AL. 1972. Degradation of abnormal proteins in Escherichia coli. PNAS 69:2422–26
     [Google Scholar]
  51. Goldberg AL. 2012. Development of proteasome inhibitors as research tools and cancer drugs. J. Cell Biol. 199:4583–88
     [Google Scholar]
  52. Goldberg AL, Dice JF. 1974. Intracellular protein degradation in mammalian and bacterial cells. Annu. Rev. Biochem. 43:835–69
     [Google Scholar]
  53. Gomez-Pastor R, Burchfiel ET, Thiele DJ. 2018. Regulation of heat shock transcription factors and their roles in physiology and disease. Nat. Rev. Mol. Cell Biol. 19:4–19
     [Google Scholar]
  54. Guggenheim KY. 1991. Rudolf Schoenheimer and the concept of the dynamic state of body constituents. J. Nutr. 121:111701–4
     [Google Scholar]
  55. Gunjan A, Verreault A. 2003. A Rad53 kinase-dependent surveillance mechanism that regulates histone protein levels in S. cerevisiae. Cell 115:5537–49
     [Google Scholar]
  56. Hara K, Yonezawa K, Weng Q-P, Kozlowski MT, Belham C, Avruch J. 1998. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 273:2314484–94
     [Google Scholar]
  57. Harper JW, Bennett EJ. 2016. Proteome complexity and the forces that drive proteome imbalance. Nature 537:7620328–38
     [Google Scholar]
  58. Harrigan JA, Jacq X, Martin NM, Jackson SP. 2018. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat. Rev. Drug Discov. 17:57–78
     [Google Scholar]
  59. Hartwell LH, Weinert TA. 1989. Checkpoints: controls that ensure the order of cell cycle events. Science 246:4930629–34
     [Google Scholar]
  60. Hershko A. 2005. Brief history of protein degradation and the ubiquitin system. Protein Degradation: Ubiquitin and the Chemistry of Life, Vol. 1 RJ Mayer, A Ciechanover, M Rechsteiner 1–9 Weinheim, Ger: Wiley-VCH
     [Google Scholar]
  61. Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425–79
     [Google Scholar]
  62. Hogness DS, Cohn M, Monod J. 1955. Studies on the induced synthesis of beta-galactosidase in Escherichia coli: the kinetics and mechanism of sulfur incorporation. Biochim. Biophys. Acta. 16:199–116
     [Google Scholar]
  63. Isaac RS, McShane E, Churchman LS. 2018. The multiple levels of mitonuclear coregulation. Annu. Rev. Genet. 52:511–33
     [Google Scholar]
  64. Ivan M, Kaelin WG Jr. 2001. The von Hippel–Lindau tumor suppressor protein. Curr. Opin. Genet. Dev. 11:127–34
     [Google Scholar]
  65. Jensen TJ, Loo MA, Pind S, Williams DB, Goldberg AL, Riordan JR. 1995. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83:1129–35
     [Google Scholar]
  66. Jewell UR, Kvietikova I, Scheid A, Bauer C, Wenger RH, Gassmann M. 2001. Induction of HIF-1α in response to hypoxia is instantaneous. FASEB J 15:71312–14
     [Google Scholar]
  67. Joazeiro CAP. 2019. Mechanisms and functions of ribosome-associated protein quality control. Nat. Rev. Mol. Cell Biol. 20:6368–83
     [Google Scholar]
  68. Jung CH, Jun CB, Ro S-H, Kim Y-M, Otto NM et al. 2009. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol. Biol. Cell 20:71992–2003
     [Google Scholar]
  69. Juszkiewicz S, Hegde RS. 2018. Quality control of orphaned proteins. Mol. Cell 71:3443–57
     [Google Scholar]
  70. Kaneko M, Ishiguro M, Niinuma Y, Uesugi M, Nomura Y. 2002. Human HRD1 protects against ER stress-induced apoptosis through ER-associated degradation. FEBS Lett 532:1–2147–52
     [Google Scholar]
  71. Kawabe H, Stegmüller J. 2021. The role of E3 ubiquitin ligases in synapse function in the healthy and diseased brain. Mol. Cell. Neurosci. 112:103602
     [Google Scholar]
  72. Keele GR, Zhang T, Pham DT, Vincent M, Bell TA et al. 2021. Regulation of protein abundance in genetically diverse mouse populations. Cell Genom 1:1100003
     [Google Scholar]
  73. Kelly A, Powis SH, Glynne R, Radley E, Beck S, Trowsdale J. 1991. Second proteasome-related gene in the human MHC class II region. Nature 353:6345667–68
     [Google Scholar]
  74. Kim J, Kundu M, Viollet B, Guan K-L. 2011. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13:2132–41
     [Google Scholar]
  75. Klein T, Eckhard U, Dufour A, Solis N, Overall CM. 2018. Proteolytic cleavage-mechanisms, function, and “omic” approaches for a near-ubiquitous posttranslational modification. Chem. Rev. 118:31137–68
     [Google Scholar]
  76. Kloetzel PM. 2004. Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. Nat. Immunol. 5:7661–69
     [Google Scholar]
  77. Knecht E, Hernández-Yago J, Martinez-Ramón A, Grisolía S. 1980. Fate of proteins synthesized in mitochondria of cultured mammalian cells revealed by electron microscope radioautography. Exp. Cell Res. 125:1191–99
     [Google Scholar]
  78. Kraft C, Deplazes A, Sohrmann M, Peter M. 2008. Mature ribosomes are selectively degraded upon starvation by an autophagy pathway requiring the Ubp3p/Bre5p ubiquitin protease. Nat. Cell Biol. 10:5602–10
     [Google Scholar]
  79. Lam YW, Lamond AI, Mann M, Andersen JS. 2007. Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Curr. Biol. 17:9749–60
     [Google Scholar]
  80. Lane DP. 1992. p53, guardian of the genome. Nature 358:15–16
     [Google Scholar]
  81. Larsson AJM, Johnsson P, Hagemann-Jensen M, Hartmanis L, Faridani OR et al. 2019. Genomic encoding of transcriptional burst kinetics. Nature 565:7738251–54
     [Google Scholar]
  82. Lecker SH, Solomon V, Mitch WE, Goldberg AL 1999. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J. Nutr. 129:1S Suppl.227S–37S
     [Google Scholar]
  83. Levine AJ. 2020. p53: 800 million years of evolution and 40 years of discovery. Nat. Rev. Cancer 20:8471–80
     [Google Scholar]
  84. Li L, Freudenberg J, Cui K, Dale R, Song S-H et al. 2013. Ldb1-nucleated transcription complexes function as primary mediators of global erythroid gene activation. Blood 121:224575–85
     [Google Scholar]
  85. Li W, Bengtson MH, Ulbrich A, Matsuda A, Reddy VA et al. 2008. Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLOS ONE 3:1e1487
     [Google Scholar]
  86. Liu GY, Sabatini DM. 2020. mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Biol. 21:4183–203
     [Google Scholar]
  87. Mann M. 2006. Functional and quantitative proteomics using SILAC. Nat. Rev. 7:952–58
     [Google Scholar]
  88. McShane E, Sin C, Zauber H, Wells JN, Donnelly N et al. 2016. Kinetic analysis of protein stability reveals age-dependent degradation. Cell 167:3803–15.e21
     [Google Scholar]
  89. Minami Y, Weissman AM, Samelson LE, Klausner RD. 1987. Building a multichain receptor: synthesis, degradation, and assembly of the T-cell antigen receptor. PNAS 84:92688–92
     [Google Scholar]
  90. Mirauta BA, Seaton DD, Bensaddek D, Brenes A, Bonder MJ et al. 2020. Population-scale proteome variation in human induced pluripotent stem cells. eLife 9:e57390
     [Google Scholar]
  91. Morgenstern M, Peikert CD, Lübbert P, Suppanz I, Klemm C et al. 2021. Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. Cell Metab 33:122464–83.e18
     [Google Scholar]
  92. Muller PAJ, Vousden KH. 2013. p53 mutations in cancer. Nat. Cell Biol. 15:2–8
     [Google Scholar]
  93. Murata S, Takahama Y, Kasahara M, Tanaka K. 2018. The immunoproteasome and thymoproteasome: functions, evolution and human disease. Nat. Immunol. 19:9923–31
     [Google Scholar]
  94. Musacchio A. 2015. The molecular biology of spindle assembly checkpoint signaling dynamics. Curr. Biol. 25:20R1002–18
     [Google Scholar]
  95. Narayanan S, Cai C-Y, Assaraf YG, Guo H-Q, Cui Q et al. 2020. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance. Drug Resist. Updat. 48:100663
     [Google Scholar]
  96. Nargund AM, Fiorese CJ, Pellegrino MW, Deng P, Haynes CM. 2015. Mitochondrial and nuclear accumulation of the transcription factor ATFS-1 promotes OXPHOS recovery during the UPRmt. Mol. Cell 58:1123–33
     [Google Scholar]
  97. Nargund AM, Pellegrino MW, Fiorese CJ, Baker BM, Haynes CM. 2012. Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation. Science 337:6094587–90
     [Google Scholar]
  98. Nguyen AT, Prado MA, Schmidt PJ, Sendamarai AK, Wilson-Grady JT et al. 2017. UBE2O remodels the proteome during terminal erythroid differentiation. Science 357:6350aan0218
     [Google Scholar]
  99. Novak B, Tyson JJ, Gyorffy B, Csikasz-Nagy A. 2007. Irreversible cell-cycle transitions are due to systems-level feedback. Nat. Cell Biol. 9:7724–28
     [Google Scholar]
  100. Ordureau A, Kraus F, Zhang J, An H, Park S et al. 2021. Temporal proteomics during neurogenesis reveals large-scale proteome and organelle remodeling via selective autophagy. Mol. Cell 81:245082–98.e11
     [Google Scholar]
  101. Ortiz-Navarrete V, Seelig A, Gernold M, Frentzel S, Kloetzel PM, Hämmerling GJ. 1991. Subunit of the “20S” proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex. Nature 353:6345662–64
     [Google Scholar]
  102. Phillips BP, Gomez-Navarro N, Miller EA. 2020. Protein quality control in the endoplasmic reticulum. Curr. Opin. Cell Biol. 65:96–102
     [Google Scholar]
  103. Pine MJ. 1967. Response of intracellular proteolysis to alteration of bacterial protein and the implications in metabolic regulation. J. Bacteriol. 93:51527–33
     [Google Scholar]
  104. Prevosto C, Usmani MF, McDonald S, Gumienny AM, Key T et al. 2016. Allele-independent turnover of human leukocyte antigen (HLA) class Ia molecules. PLOS ONE 11:8e0161011
     [Google Scholar]
  105. Qi L, Tsai B, Arvan P. 2017. New insights into the physiological role of endoplasmic reticulum-associated degradation. Trends Cell Biol 27:6430–40
     [Google Scholar]
  106. Rabinovitz M, Fisher JM. 1964. Characteristics of the inhibition of hemoglobin synthesis in rabbit reticulocytes by threo-α-amino-β-chlorobutyric acid. Biochim. Biophys. Acta. 91:313–22
     [Google Scholar]
  107. Radzicka A, Wolfenden R. 1996. Rates of uncatalyzed peptide bond hydrolysis in neutral solution and the transition state affinities of proteases. J. Amer. Chem. Soc. 118:266105–9
     [Google Scholar]
  108. Ramachandran KV, Fu JM, Schaffer TB, Na CH, Delannoy M, Margolis SS. 2018. Activity-dependent degradation of the nascentome by the neuronal membrane proteasome. Mol. Cell 71:1169–77.e6
     [Google Scholar]
  109. Ramachandran KV, Margolis SS. 2017. A mammalian nervous-system-specific plasma membrane proteasome complex that modulates neuronal function. Nat. Struct. Mol. Biol. 24:4419–30
     [Google Scholar]
  110. Ramsey JJ, Harper ME, Weindruch R. 2000. Restriction of energy intake, energy expenditure, and aging. Free Radic. Biol. Med. 29:10946–68
     [Google Scholar]
  111. Roche PA, Furuta K. 2015. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat. Rev. Immunol. 15:4203–16
     [Google Scholar]
  112. Rock KL, Farfán-Arribas DJ, Colbert JD, Goldberg AL. 2014. Re-examining class-I presentation and the DRiP hypothesis. Trends Immunol 35:4144–52
     [Google Scholar]
  113. Rock KL, Gramm C, Rothstein L, Clark K, Stein R et al. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:5761–71
     [Google Scholar]
  114. Rock KL, York IA, Goldberg AL. 2004. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat. Immunol. 5:7670–77
     [Google Scholar]
  115. Ross AB, Langer JD, Jovanovic M. 2020. Proteome turnover in the spotlight: approaches, applications, and perspectives. Mol. Cell. Proteom. 20:100016
     [Google Scholar]
  116. Roux-Dalvai F, Gonzalez de Peredo A, Simó C, Guerrier L, Bouyssié D et al. 2008. Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol. Cell. Proteom. 7:112254–69
     [Google Scholar]
  117. Ruben S, Kamen MD. 1941. Long-lived radioactive carbon: C14. Phys. Rev. 59:4349–54
     [Google Scholar]
  118. Sacramento EK, Kirkpatrick JM, Mazzetto M, Baumgart M, Bartolome A et al. 2020. Reduced proteasome activity in the aging brain results in ribosome stoichiometry loss and aggregation. Mol. Syst. Biol. 16:e9596
     [Google Scholar]
  119. Schimke RT. 1964. The importance of both synthesis and degradation in the control of arginase levels in rat liver. J. Biol. Chem. 239:3808–17
     [Google Scholar]
  120. Schoenheimer R, Ratner S, Rittenberg D, Heidelberger M. 1942. The interaction of antibody protein with dietary nitrogen in actively immunized animals. J. Biol. Chem. 144:2545–54
     [Google Scholar]
  121. Schoenheimer R, Rittenberg D. 1935. Deuterium as an indicator in the study of intermediary metabolism. Science 82:2120156–57
     [Google Scholar]
  122. Schoenheimer R, Rittenberg D. 1938. The application of isotopes to the study of intermediary metabolism. Science 87:2254221–26
     [Google Scholar]
  123. Schubert U, Antón LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR. 2000. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:6779770–74
     [Google Scholar]
  124. Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J et al. 2011. Global quantification of mammalian gene expression control. Nature 473:7347337–42
     [Google Scholar]
  125. Schwanhäusser B, Wolf J, Selbach M, Busse D. 2013. Synthesis and degradation jointly determine the responsiveness of the cellular proteome. Bioessays 35:7597–601
     [Google Scholar]
  126. Schwarz A, Beck M. 2019. The benefits of cotranslational assembly: a structural perspective. Trends Cell Biol. 29:10791–803
     [Google Scholar]
  127. Schweers RL, Zhang J, Randall MS, Loyd MR, Li W et al. 2007. NIX is required for programmed mitochondrial clearance during reticulocyte maturation. PNAS 104:4919500–5
     [Google Scholar]
  128. Semenza GL, Wang GL. 1992. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12:125447–54
     [Google Scholar]
  129. Senger G, Schaefer MH. 2021. Protein complex organization imposes constraints on proteome dysregulation in cancer. Front. Bioinform 1:33
     [Google Scholar]
  130. Shah AM, Wondisford FE. 2020. Tracking the carbons supplying gluconeogenesis. J. Biol. Chem. 295:4214419–29
     [Google Scholar]
  131. Shemorry A, Hwang C-S, Varshavsky A. 2013. Control of protein quality and stoichiometries by N-terminal acetylation and the N-end rule pathway. Mol. Cell 50:4540–51
     [Google Scholar]
  132. Shpilka T, Haynes CM. 2018. The mitochondrial UPR: mechanisms, physiological functions and implications in ageing. Nat. Rev. Mol. Cell Biol. 19:2109–20
     [Google Scholar]
  133. Song J, Herrmann JM, Becker T. 2021. Quality control of the mitochondrial proteome. Nat. Rev. Mol. Cell Biol. 22:54–70
     [Google Scholar]
  134. Soto I, Couvillion M, McShane E, Hansen KG, Conor Moran J et al. 2021. Balanced mitochondrial and cytosolic translatomes underlie the biogenesis of human respiratory complexes. bioRxiv 446345. https://doi.org/10.1101/2021.05.31.446345
    [Crossref]
  135. Stiburek L, Cesnekova J, Kostkova O, Fornuskova D, Vinsova K et al. 2012. YME1L controls the accumulation of respiratory chain subunits and is required for apoptotic resistance, cristae morphogenesis, and cell proliferation. Mol. Biol. Cell 23:61010–23
     [Google Scholar]
  136. Sung M-K, Porras-Yakushi TR, Reitsma JM, Huber FM, Sweredoski MJ et al. 2016. A conserved quality-control pathway that mediates degradation of unassembled ribosomal proteins. eLife 5:e19105
     [Google Scholar]
  137. Suraweera A, Münch C, Hanssum A, Bertolotti A. 2012. Failure of amino acid homeostasis causes cell death following proteasome inhibition. Mol. Cell 48:2242–53
     [Google Scholar]
  138. Swatek KN, Komander D. 2016. Ubiquitin modifications. Cell Res 26:4399–422
     [Google Scholar]
  139. Swovick K, Welle KA, Hryhorenko JR, Seluanov A, Gorbunova V, Ghaemmaghami S. 2018. Cross-species comparison of proteome turnover kinetics. Mol. Cell. Proteom. 17:4580–91
     [Google Scholar]
  140. Taggart JC, Li G-W. 2018. Production of protein-complex components is stoichiometric and lacks general feedback regulation in eukaryotes. Cell Syst 7:6580–89.e4
     [Google Scholar]
  141. Taggart JC, Zauber H, Selbach M, Li G-W, McShane E. 2020. Keeping the proportions of protein complex components in check. Cell Syst 10:2125–32
     [Google Scholar]
  142. Tai H-C, Schuman EM. 2008. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat. Rev. Neurosci. 9:826–38
     [Google Scholar]
  143. Taylor AM, Shih J, Ha G, Gao GF, Zhang X et al. 2018. Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell 33:4676–89.e3
     [Google Scholar]
  144. Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM. 2012. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485:7396109–13
     [Google Scholar]
  145. Townsend AR, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:6959–68
     [Google Scholar]
  146. Toyama BH, Hetzer MW. 2013. Protein homeostasis: live long, won't prosper. Nat. Rev. Mol. Cell Biol. 14:55–61
     [Google Scholar]
  147. Toyama BH, Savas JN, Park SK, Harris MS, Ingolia NT et al. 2013. Identification of long-lived proteins reveals exceptional stability of essential cellular structures. Cell 154:5971–82
     [Google Scholar]
  148. Trentini DB, Pecoraro M, Tiwary S, Cox J, Mann M et al. 2020. Role for ribosome-associated quality control in sampling proteins for MHC class I-mediated antigen presentation. PNAS 117:84099–108
     [Google Scholar]
  149. Tye BW, Commins N, Ryazanova LV, Wühr M, Springer M et al. 2019. Proteotoxicity from aberrant ribosome biogenesis compromises cell fitness. eLife 8:e43002
     [Google Scholar]
  150. Vodermaier HC. 2004. APC/C and SCF: controlling each other and the cell cycle. Curr. Biol. 14:18R787–96
     [Google Scholar]
  151. von Liebig JF. 1842. Die organische Chemie in ihrer Anwendung auf Physiologie und Pathologie [Organic chemistry in its application to physiology and pathology] Frankfurt am Main Ger.: F. Vieweg und Sohn
     [Google Scholar]
  152. Wang F, Durfee LA, Huibregtse JM. 2013. A cotranslational ubiquitination pathway for quality control of misfolded proteins. Mol. Cell 50:3368–78
     [Google Scholar]
  153. Ward CL, Kopito RR. 1994. Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. J. Biol. Chem. 269:4125710–18
     [Google Scholar]
  154. Weidemann A, Johnson RS. 2008. Biology of HIF-1α. Cell Death Differ 15:4621–27
     [Google Scholar]
  155. Wiśniewski JR, Hein MY, Cox J, Mann M. 2014. A “proteomic ruler” for protein copy number and concentration estimation without spike-in standards. Mol. Cell. Proteom. 13:123497–506
     [Google Scholar]
  156. Wyant GA, Abu-Remaileh M, Frenkel EM, Laqtom NN, Dharamdasani V et al. 2018. NUFIP1 is a ribosome receptor for starvation-induced ribophagy. Science 360:6390751–58
     [Google Scholar]
  157. Yanagitani K, Juszkiewicz S, Hegde RS. 2017. UBE2O is a quality control factor for orphans of multiprotein complexes. Science 357:6350472–75
     [Google Scholar]
  158. Yau R, Rape M. 2016. The increasing complexity of the ubiquitin code. Nat. Cell Biol. 18:6579–86
     [Google Scholar]
  159. Yewdell JW, Antón LC, Bennink JR. 1996. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?. J. Immunol. 157:51823–26
     [Google Scholar]
  160. Zhao J, Zhai B, Gygi SP, Goldberg AL. 2015. mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy. PNAS 52:11215790–97
     [Google Scholar]
  161. Zhao Q, Wang J, Levichkin IV, Stasinopoulos S, Ryan MT, Hoogenraad NJ. 2002. A mitochondrial specific stress response in mammalian cells. EMBO J 21:174411–19
     [Google Scholar]
  162. Zheng N, Shabek N. 2017. Ubiquitin ligases: structure, function, and regulation. 2017. Annu. Rev. Biochem. 86:129–57
     [Google Scholar]
/content/journals/10.1146/annurev-cellbio-120420-091943
Loading
Physiological Functions of Intracellular Protein Degradation
Annual Review of Cell and Developmental Biology 38, 241 (2022); https://doi.org/10.1146/annurev-cellbio-120420-091943
/content/journals/10.1146/annurev-cellbio-120420-091943
/content/journals/10.1146/annurev-cellbio-120420-091943
Loading

Data & Media loading...

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error